drugset / Trial / NCT03695432

Probiotic and Influenza Vaccination to Reducing Influenza-like Illness Incident in Elderly

NCT03695432

Phase 4 Completed 910 enrolled Indonesia University
RandomizedFactorialSingle-blindPrevention

Summary

To asses the effect of the probiotic and influenza vaccination alone and combination on enhancing immune response to influenza-like illness (ILI) and reducing ILI incidence in the elderly

Timeline

Start
2014-10
Primary completion
2015-04
Completion
2016-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Influenza Virus Vaccine Vaccine 0.5 ml Intramuscular

Indications